Related Experiment Video
Updated: Aug 29, 2026

Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Published on: January 9, 2019
Reversible anosmia after amikacin therapy
Antje Welge-Luessen1, Markus Wolfensberger
1Department of Otorhinolaryngology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. awelge@uhbs.ch
Abstract:
Olfactory disorders are among the rare adverse effects of antibiotic therapy. To date, olfactory losses or distortions have been reported after the use of doxycycline, amoxicillin, clarithromycin, roxithromycin, kanamycin sulfate, and streptomycin sulfate. We describe what we believe to be the first case of transient anosmia associated with the use of intravenous amikacin sulfate. The appearance of the disorder and its subsequent resolution were demonstrated by psychometric testing as well as by chemosensory evoked potentials. Based on the well-documented temporal course of the anosmia, there is a probable causal correlation between the administration of amikacin and the appearance of the olfactory disturbance. However, the exact pathogenesis of the anosmia is still a matter of conjecture.
Insights
Antibiotic therapy can rarely cause olfactory disorders. This study reports the first case of temporary smell loss (anosmia) linked to intravenous amikacin sulfate, with probable causal correlation.
Area of Science:
- Pharmacology
- Neuroscience
- Otolaryngology
Background:
- Olfactory disorders are rare adverse effects of antibiotic treatments.
- Previous reports documented olfactory disturbances with doxycycline, amoxicillin, clarithromycin, roxithromycin, kanamycin sulfate, and streptomycin sulfate.
Observation:
- This study details the first reported case of transient anosmia (complete loss of smell) following intravenous administration of amikacin sulfate.
- The onset and recovery of the olfactory disorder were objectively measured using psychometric testing and chemosensory evoked potentials.
Findings:
- A probable causal link was established between amikacin sulfate administration and the development of olfactory disturbance.
- The temporal relationship between drug administration and the olfactory symptoms strongly suggests a correlation.
Implications:
- This case highlights amikacin sulfate as a potential cause of drug-induced olfactory dysfunction.
- Further research is needed to elucidate the precise mechanisms underlying amikacin-induced anosmia.
Related Concept Videos
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Suctioning the Nasopharyngeal Airway
Equipment Required

